Get started
444

GENERAL BIOLOGICAL CORP

No trades
See on Supercharts
Overview
Financials Discussions Technicals Seasonals

4117 chart


Full chart

4117 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.11 B‬ TWD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−3.50 TWD
Net income (FY)
‪−198.83 M‬ TWD
Revenue (FY)
‪264.82 M‬ TWD
Shares float
—
Beta (1Y)
0.32

About GENERAL BIOLOGICAL CORP


Sector
Health Technology
Industry
Medical Specialties
CEO
Meng Te Lin
Website
gbc.com.tw
Headquarters
Hsinchu
Founded
1984
ISIN
TW0004117007
FIGI
BBG000BXDZL9
General Biologicals Corp. engages in research, development, manufacture and trade of diagnostics and pharmaceutical. The company provides anti-bacterial peptide in areas of pharmaceutical, cosmetics, and oral products. Its products include in vitro diagnostic (IVD) kits & system; raw materials & reagents; point-of-care testing; and automated pipetting system. General Biologicals was founded on June 11, 1984 and is headquartered in Hsinchu, Taiwan.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Technicals

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4117 is 18.50 TWD — it has increased by 1.65% in the past 24 hours. Watch GENERAL BIOLOGICAL CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TPEX exchange GENERAL BIOLOGICAL CORP stocks are traded under the ticker 4117.
4117 stock has risen by 1.65% compared to the previous week, the month change is a −2.63% fall, over the last year GENERAL BIOLOGICAL CORP has showed a −20.26% decrease.
4117 reached its all-time high on Jul 7, 2020 with the price of 273.50 TWD, and its all-time low was 1.75 TWD and was reached on May 5, 2010. View more price dynamics on 4117 chart.
See other stocks reaching their highest and lowest prices.
4117 stock is 3.93% volatile and has beta coefficient of 0.32. Track GENERAL BIOLOGICAL CORP stock price on the chart and check out the list of the most volatile stocks — is GENERAL BIOLOGICAL CORP there?
Yes, you can track GENERAL BIOLOGICAL CORP financials in yearly and quarterly reports right on TradingView.
GENERAL BIOLOGICAL CORP is going to release the next earnings report on Feb 26, 2025. Keep track of upcoming events with our Earnings Calendar.
4117 net income for the last half-year is ‪−106.02 M‬ TWD, while the previous report showed ‪−103.29 M‬ TWD of net income which accounts for −2.64% change. Track more GENERAL BIOLOGICAL CORP financial stats to get the full picture.
No, 4117 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GENERAL BIOLOGICAL CORP EBITDA is ‪−139.94 M‬ TWD, and current EBITDA margin is −50.32%. See more stats in GENERAL BIOLOGICAL CORP financial statements.
Like other stocks, 4117 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENERAL BIOLOGICAL CORP stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENERAL BIOLOGICAL CORP technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENERAL BIOLOGICAL CORP stock shows the sell signal. See more of GENERAL BIOLOGICAL CORP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.